Genetically engineered hemoglobin (GEH) refers to hemoglobin molecules that have been altered through genetic engineering techniques. These modifications aim to enhance the oxygen-carrying capacity, improve stability, or reduce immunogenicity. Common approaches involve gene editing tools like CRISPR-Cas9, which allow precise modifications to the DNA sequence encoding hemoglobin.
